PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0027051|myocardial infarction |
| Sentences | 20 |
| PubMedID- 22971940 | Presence of metabolic syndrome is associated with larger myocardial infarction size and complications following acute myocardial infarction. |
| PubMedID- 25789257 | However, very limited clinical data have addressed myocardial infarction size in patients with metabolic syndrome comparing to control subjects without metabolic syndrome. |
| PubMedID- 23411742 | Aim: aim of this study was to determine the prevalence of metabolic syndrome in patients with premature myocardial infarction (before 50 years of age). |
| PubMedID- 25563711 | Effect of angiotensin converting enzyme inhibitors on periprocedural myocardial infarction in patients with metabolic syndrome. |
| PubMedID- 22701134 | Clinical impact of non-high density lipoprotein-cholesterol and apolipoprotein b on clinical outcomes in metabolic syndrome patients with acute myocardial infarction undergoing percutaneous coronary intervention. |
| PubMedID- 23934969 | Objective: this study aimed to evaluate long-term survival according to the presence of metabolic syndrome (ms) in patients with acute myocardial infarction (ami) undergoing successful percutaneous coronary intervention (pci) with drug-eluting stents (des). |
| PubMedID- 19356813 | Obesity and the metabolic syndrome in patients with acute myocardial infarction. |
| PubMedID- 21757819 | Background: the purpose of the present study was to compare the efficacy and safety of paclitaxel-eluting stent (pes), sirolimus-eluting stent (ses), and zotarolimus-eluting stent (zes) in primary percutaneous coronary intervention (pci) for acute st-segment elevation myocardial infarction (stemi) with metabolic syndrome (ms). |
| PubMedID- 21487455 | Patient was diagnosed with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, further complicated by non-st elevation myocardial infarction (nstemi), and acute pancreatitis based on the peripheral smear, thrombocytopenia, hemolytic anemia, acute renal failure, elevated cardiac biomarkers and elevated pancreatic enzymes. |
| PubMedID- 20811489 | We sought to determine and compare the prevalence of the metabolic syndrome (ms) in patients with acute myocardial infarction (ami) utilizing the new international diabetes federation (idf) definition with the older national cholesterol education program (ncep) definition. |
| PubMedID- 21646744 | Heart failure mimicking prior myocardial infarction in a patient with idiopathic hypereosinophilic syndrome. |
| PubMedID- 24020829 | Intra-thoracic fat volume is associated with myocardial infarction in patients with metabolic syndrome. |
| PubMedID- 22240598 | Coronary artery bypass grafting for multivessel coronary artery disease in metabolic syndrome patients with acute myocardial infarction. |
| PubMedID- 23715346 | Considering inclusion and exclusion criteria total 100 patients were included and divided into two groups, group a - acute myocardial infarction (ami) with metabolic syndrome (ms) and group b - acute myocardial infarction (ami) without metabolic syndrome (ms). |
| PubMedID- 21129152 | It also reduced the risk of myocardial infarction in patients with severe metabolic syndrome by 56% (8 year follow-up) and the development of type 2 diabetes by almost half (2 and 5 year follow-up) [26]. |
| PubMedID- 21428179 | Conclusion: elevated homocysteine levels were correlated to the metabolic syndrome in patients with prior myocardial infarction. |
| PubMedID- 21159478 | Acute inferior myocardial infarction with nephrotic syndrome. |
| PubMedID- 22263382 | Metabolic syndrome and outcome in patients with acute myocardial infarction. |
| PubMedID- 20509277 | Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction). |
| PubMedID- 20890426 | We sought to determine the prevalence of metabolic syndrome (ms) in patients with acute myocardial infarction and its effect on clinical outcomes. |
Page: 1